ENTITY
Broncus

Broncus (2216 HK)

21
Analysis
Health Care • China
Broncus is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company provides diagnostic solutions, lung cancer treatment solutions, and chronic obstructive pulmonary disease (COPD) solutions, including navigation platforms and interventional therapeutic devices like the InterVapor system and BroncAblate. Broncus was founded in 2012 and is headquartered in Hangzhou, China.
more
bearish•Broncus
•12 Sep 2021 15:25

Broncus (堃博医疗) Pre-IPO: Thoughts on Valuation

We provide key assumptions for the forecast of Broncus' financials and pre-money valuation. The company is fairly valued based on forward EV/Sales...

Logo
483 Views
Share
bullish•Broncus
•08 Sep 2021 03:10

Broncus Holdings IPO: Say No to Lung Diseases

Broncus' core products have a competitive edge over its competition due to their unique features, helping it to capture more of the growing...

Share
bullish•Broncus
•07 Sep 2021 23:14

Broncus IPO: Every Breath They Take

Broncus is pre-marketing an HKEx IPO to raise $300m. The core products' differentiation in terms of technology and target indications increases the...

Logo
393 Views
Share
bullish•Broncus
•30 Jun 2021 09:31

Pre-IPO Broncus Holding Corporation - The Strength and the Concerns

This article mainly analyzed Broncus in terms of the industry characteristics, the core products, and the concerns of the Company.

Logo
583 Views
Share
bullish•Eternal
•23 May 2021 10:33

ECM Weekly (23rd May 2021) - Zomato, Angelalign, Youran Dairy, Central China Mgt, Broncus, ForU

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
x